FDA Inspection 1163279 — Rhode Island Blood Center, a Division of New York Blood Center, Inc. Aquidneck Island Donor Center

Rhode Island Blood Center, a Division of New York Blood Center, Inc. Aquidneck Island Donor Center — FEI 1000159706

The FDA completed an inspection of Rhode Island Blood Center, a Division of New York Blood Center, Inc. Aquidneck Island Donor Center on February 9, 2022 in Middletown, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 9, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Middletown, RI (United States)